CTRI/2022/03/040797CompletedPhase 2
Pre clinical and clinical evaluation of the effect on oral administration of KIRAMBU CHOORANAM along with VARMA THERAPY in the management of VALIPPU NOI IN PEDIATRIC AGE GROUP
Dr R Elamathi0 sites40 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patient with seizure or history of seizure
- •Patient who had taken anti psychiatric drugs
- •Patient with febrile fits
- •Seizure due to cerebral palsy, hypoxic ischaemic encephalopathy
Exclusion Criteria
- •Children above 12 years
- •Non epileptic seizure events ( pseudoseizures)
- •Toxic ingestion
- •Seizure due to SOL
- •Seizure due to trauma
- •Status epilepticus
- •Brain tumour
Investigators
Similar Trials
Completed
Phase 2
Pre clinical and Clinical evaluation of KARAPPAN CHOORANAM (oral administration) and ERULI ENNAI (external application) in the management of Atopic dermatitisCTRI/2022/03/040769Dr Rajeetha Miraaj
Completed
Phase 2
preclinical and clinical evaluation of the effect of siddha classical drug KANAI KIRUTHAM(oral administration)in the management of WHEEZING ASSOCIATED LOWER RESPIRATORY TRACT INFECTIOCTRI/2022/02/039924Dr J Jayamani40
Completed
Phase 2
Preclinical and clinical evaluation of POONAI MEESAI CHOORANAM KUDINEER (Oral administration) in the management of NEPHROTIC SYNDROMECTRI/2022/03/040774Dr P Narmatha40
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreCTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childreCTRI/2022/01/039863Dr S Surendar